CD163 expression tends to be low in conditions such as non-alcoholic fatty liver (39, 46) and ischemic cardiomyopathy (47), whereas sCD163 tends to be elevated in hypertension (48) and diabetes (49, 50). This evidence concerns the gene CD163 and hypertensive disorder.